EU inches closer to new pharma legislation amid competitiveness drive
The framework has had a lukewarm reaction, with trade association EFPIA saying the policies are “not strong enough”.
Business & Regulation
BIOSECURE Act set for Congress vote after inclusion in annual defence bill
Former FDA commissioners unite to condemn US vaccine proposals
House passes bill that reauthorises the FDA’s paediatric priority voucher pathway
UK and US strike “landmark” zero-tariff pharma deal
Novo Nordisk latest outlook trim shows “quick momentum loss”
Tidmarsh’s FDA exit marks latest high-profile jockeying at US agencies
Kimberly-Clark buys troubled Tylenol-maker Kenvue for $48.7bn
